Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04224272
Title A Study of ZW25 (Zanidatamab) With Palbociclib Plus Fulvestrant in Patients With HER2+/HR+ Advanced Breast Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Zymeworks Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP | CAN

Facility Status City State Zip Country Details
UCLA Hematology/Oncology Parkside Santa Monica California 90404 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
Seattle Cancer Care Alliance Seattle Washington 98109 United States Details
Tom Baker Cancer Centre Calgary Alberta T2N4N2 Canada Details
The Ottawa Hospital Cancer Centre Ottawa Ontario K1H 8L6 Canada Details
Sunnybrook Research Institute Toronto Ontario M4N3M5 Canada Details
Jewish General Hospital Montreal Quebec H3T1E2 Canada Details
Hospital General Universitario de Elche Elche Alicante 03203 Spain Details
Hospital Universitario Vall d'Hebrón Barcelona 08035 Spain Details
Hospital Ruber Internacional Madrid 28034 Spain Details
Hospital Universitario Virgen de la Victoria Málaga 29010 Spain Details
Hospital Universitario Virgen del Rocío Sevilla 41013 Spain Details
Hospital Clínico Universitario de Valencia Valencia 46010 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field